Publication date: December 2026 Source: American Journal of Ophthalmology, Volume 292 Author(s): Raj Kundu, Nathan Goturi, Michael Green, Vasiliki Poulaki, Nicole H. Siegel, Manju L. Subramanian, Steven Ness
Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema. // American Journal of Ophthalmology. – URL: https://www.sciencedirect.com/science/article/pii/S0002939426005040?dgcid=rss_sd_all
Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema. American Journal of Ophthalmology. https://www.sciencedirect.com/science/article/pii/S0002939426005040?dgcid=rss_sd_all
“Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema.” American Journal of Ophthalmology.
@article{article99609,
title = {Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema},
journal = {American Journal of Ophthalmology},
url = {https://www.sciencedirect.com/science/article/pii/S0002939426005040?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...